RxCell

Singapore, Singapore

RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).

$4.6M raised

Dec 2023

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has RxCell raised?

RxCell has raised $4.6M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are RxCell's investors?

RxCell's investors include Regenosis, DMR Global Venture.

Where is RxCell headquartered?

RxCell is headquartered in Singapore, Singapore.

What does RxCell do?

RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).

What stage is RxCell at?

RxCell is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 5, 2023.

MLA

"RxCell — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/rxcell. Accessed July 3, 2026.

APA

VCBacked. (2023). RxCell — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/rxcell

Wikipedia (cite web)

{{cite web |title=RxCell — Funding & Investors |url=https://www.vcbacked.co/company/rxcell |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 5, 2023.